Key Studies:
Wilson B, Eyice O, Koumoutsos I, Lomer MC, Irving PM, Lindsay JO, Whelan K. Prebiotic
Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the
Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms.
Nutrients 2021, 13, 3598. Access the study>> 

Williams, NC, Johnson MA, Shaw DE, Spendlove I, Vulevic J, Sharpe GR, Hunter KA. 2016.
A prebiotic galacto-oligosaccharide mixture (B-GOS) reduces severity of hyperpneainduced
bronchoconstriction and markers of airway inflammation. British Journal of
Nutrition, 116:798-804. Access the study>>

Vulevic J, Tzortzis G, Juric A, Gibson GR. 2018. Effect of a prebiotic
galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults
selected from a general population who suffer with bloating, abdominal pain, or
flatulence. Neurogastroenterol Motil.;30(11):e13440. Access the study>>

Vulevic J, Juric A, Walton GE, Claus SP, Tzortzis G, Toward RE, Gibson GR. 2015.
Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune
parameters and metabonomics in elderly persons. Br J Nutr.;114(4):586-95.
Access the study>>

Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. 2009. Clinical trial: the effects of
a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms
in irritable bowel syndrome. Aliment Pharmacol Ther. 1;29(5):508-18.
Access the study>>